Healthtech & Wellness VC Funds

NPV Ventures is a venture capital firm that focuses on investing in early-stage technology companies, particularly in fintech, consumer tech, and enterprise software. The firm seeks to partner with founders who are building transformative solutions that have the potential to disrupt their industries. NPV Ventures is known for its hands-on approach, working closely with its portfolio companies to provide not just capital but also strategic guidance, operational expertise, and access to a vast network of industry leaders and investors. Founded by a group of seasoned entrepreneurs and investors, NPV Ventures aims to be the first institutional capital into a startup, often investing at the seed and pre-seed stages. The firm takes pride in backing high-growth potential companies and helping them scale by leveraging their deep industry insights and connections. Their portfolio includes innovative startups that are making significant strides in their respective markets. NPV Ventures typically writes initial checks in the range of $250,000 to $1 million and continues to support its companies through follow-on investments. The firm is particularly interested in startups that are solving complex problems with scalable business models, and they prefer to work with founders who demonstrate strong vision, leadership, and execution capabilities. With a focus on both U.S. and international markets, NPV Ventures continues to play a significant role in shaping the future of the tech landscape by backing visionary entrepreneurs and game-changing companies.

Northstar Ventures is a UK-based venture capital firm focused on early-stage investments that create a positive social or environmental impact. With a portfolio that spans tech innovation and social enterprises, the firm emphasizes sectors like climate tech, biotech, and healthy aging. Their notable investments include Newcells Biotech, which develops in vitro organ models for drug testing, and NunaBio, a leader in DNA synthesis technology crucial for personalized medicine and data storage solutions​. Geographically, Northstar Ventures primarily focuses on startups in the North East of England but also supports businesses across the UK. They invest through funds such as the North East Innovation Fund and the Northstar EIS Growth Fund, with typical early-stage investments ranging from £300,000 to £1 million​. Their hands-on approach includes extensive support for founders, particularly in sectors that align with sustainability goals, like Low Carbon Materials, which develops environmentally friendly construction materials. Northstar also backs social impact ventures, such as Coping with Cancer North East, reflecting their commitment to community well-being alongside technological innovation.

Northwell Ventures is the corporate venture capital arm of Northwell Health — New York State's largest private employer and integrated healthcare delivery network, comprising 21-plus hospitals and more than 850 ambulatory sites — operating under Northwell Holdings, the system's for-profit commercialization subsidiary established in 2015. The unit is led by President and CEO Richard Mulry, a 25-plus-year veteran of healthcare administration and operations. Its mandate is to improve the future of healthcare by investing in companies that drive higher-quality outcomes, increase operating efficiency, lower the total cost of care, and improve the patient experience. Northwell Ventures leads rounds and is active from seed through Series B, and has made approximately 40 investments to date. The firm is highly selective: it receives more than 2,000 external startup inquiries per year and invests in roughly one in every 300 companies reviewed. Activity is organized across three pillars — venture investment, joint ventures and co-creation, and data strategy and commercialization. Flagship initiatives include Ascertain, a joint healthcare-AI company creation platform launched with Aegis Ventures in 2022 and 2023 and capitalized with $100 million to systematically launch AI companies for maternal and fetal health and chronic disease detection; and Clarapath, a 2021 spin-out automating pathology labs with AI-powered robotics that raised a $36 million Series B-1 in 2024 led by Northwell Ventures with Mayo Clinic and Ochsner Ventures, bringing total funding to $75 million. Other portfolio names include Optain, Hume, Prolucent, Playback Health, and Memora Health. Northwell's commercial and clinical scale gives its venture arm privileged access to real-world patient workflows and health-system data — a structural advantage that few hospital-affiliated CVCs can match.

Northwestern Mutual Future Ventures (NMFV) is the corporate venture capital arm of Northwestern Mutual, the 165-plus-year-old US life insurance and financial planning mutual. The fund launched in 2017 with an initial $50 million commitment, expanded to a $150 million second fund in May 2019, and today manages more than $300 million in assets under management out of Milwaukee, Wisconsin. The investment program was built and scaled under longtime Managing Director Craig Schedler over a 13-year tenure before his transition to Intuit Ventures in 2024; NMFV continues operating through the broader corporate venturing team. The fund deploys initial cheques of $500,000 to $5 million at Series A and Series B into US-based startups, with significant follow-on capacity. The investment thesis centers on four priority areas aligned to Northwestern Mutual's mission: consumers' changing preferences, reimagining the client experience, the digital health revolution, and transformational analytics and technologies. Across 77 lifetime investments, notable portfolio companies include Betterment, the New York-based robo-advisor pioneer; Rize, a consumer savings platform; Inclined, which raised an $8 million Series B in 2025 focused on whole-life-insurance liquidity; and Alkymi and Ocient, both invested in 2025. The most recent disclosed investment is Letter AI, a business productivity software company backed in February 2026. NMFV's strategic value to portfolio companies lies in access to Northwestern Mutual's distribution network — its more than 6,500 financial advisors serve several million clients — making the fund a meaningful commercial partner as well as a financial backer for companies building in fintech, healthtech, and analytics.

Northzone, established in 1996, is a multi-stage venture capital fund investing in companies from Seed to Growth stages across Europe and the US. With a notable portfolio that includes companies like Spotify, Klarna, Trustpilot, and Kahoot!, Northzone has built a reputation for backing category-defining entrepreneurs. In 2022, Northzone raised €1 billion, emphasizing its commitment to supporting innovative startups that can thrive amidst global challenges. The firm’s investment strategy spans various sectors, including fintech, healthtech, SaaS, and consumer technology. Northzone typically writes checks between €1 million and €40 million, allowing them to support companies through multiple stages of growth, from initial funding to pre-IPO. Their approach is characterized by a focus on founders with conviction, a willingness to embrace risk, and a dedication to long-term partnerships. Northzone’s team operates across major cities like New York, London, Stockholm, Amsterdam, and Berlin, reflecting their "glocal" (global and local) mindset. This diverse and international team, comprising 36 members from 16 nationalities, brings a wealth of experience and a strong network to the table. The firm values integrity, results, intellectual curiosity, and strong partnerships, and has consistently championed diversity and inclusion both within their team and across their portfolio. Entrepreneurs interested in partnering with Northzone are encouraged to present bold ideas with substantial market potential. The firm values straightforward communication and prefers to invest in teams capable of navigating and thriving in challenging environments

Norwest Venture Partners (NVP), headquartered in Menlo Park, California, is a prominent venture capital and growth equity investment firm managing over $15.5 billion in capital. Founded in 1961, Norwest has invested in more than 700 companies across various sectors, including enterprise, consumer, and healthcare. Some of their notable investments include companies like Spotify, Adaptive Insights, Udemy, Talkspace, Opendoor, Kendra Scott, and Health Catalyst. These investments highlight Norwest's diversified approach, backing high-impact companies at various stages of growth from early to late-stage. Norwest recently announced the closing of its seventeenth fund, NVP 17, raising $3 billion to continue supporting visionary entrepreneurs. The firm operates globally with offices in Menlo Park, San Francisco, Mumbai, and Tel Aviv, focusing on North America, India, and Israel​. With a strong commitment to their portfolio companies, Norwest offers extensive support through their experienced investment and portfolio services teams, helping businesses navigate growth and scale effectively. This hands-on approach has contributed to their track record of successful exits and sustained growth in their portfolio companies​.

Not Boring Capital, founded by Packy McCormick, is a venture capital firm that emphasizes investing in innovative and transformative startups. Established in 2019 and based in New York City, the firm has made notable investments in various sectors, including fintech, health tech, and blockchain technology. The portfolio includes companies like Footprint, which offers identity and attribute verification solutions, and Disco, a platform for customer management solutions. Other significant investments include Gilded, providing accounting and payment solutions for crypto businesses, and Union54, which focuses on correspondent banking solutions in Zambia. Not Boring Capital typically invests in early-stage ventures, particularly in seed and Series A rounds. Recent investments include Unnatural Products, a biotech firm focused on molecularly targeted therapeutics, and Atomic AI, an AI-based platform for RNA drug discovery. The firm collaborates with prominent co-investors such as Index Ventures, Bessemer Venture Partners, and Andreessen Horowitz to support these startups. By leveraging a robust network and expertise in storytelling, Not Boring Capital aims to help its portfolio companies scale effectively and reach their full potential. The firm’s strategy includes not only financial investment but also strategic guidance and brand building.

Notation Capital, established in 2015 by Nicholas Chirls and Alex Lines, is a pioneering pre-seed venture capital firm based in Brooklyn, New York. Specializing in early-stage investments, Notation Capital supports technical teams at the inception of their business journeys, often at the idea stage. Notation's notable investments include Spruce, Livepeer, Bison Trails, and Parsec, showcasing their focus on hard tech, infrastructure, and product-centric startups. The fund is heavily focused on the New York City area but does not limit itself geographically if the opportunity aligns well with their investment philosophy. They typically lead the first round of financing with investment sizes ranging from $250K to $750K. Their strategy emphasizes deep involvement from day one, providing not just capital but also substantial operational support, leveraging their extensive network of advisors, founders, and LPs to accelerate growth and product development. Key team members include Nicholas Chirls, who brings expertise in product development and growth strategies from his previous role at betaworks, and Alex Lines, a seasoned software engineer with a decade of experience in building scalable products. Startups looking to engage with Notation Capital should demonstrate a strong technical foundation and a compelling vision for disruptive innovation. They prefer founders who are deeply product-focused and exhibit a strong determination to execute their vision.

Notion Capital, founded by seasoned SaaS entrepreneurs, excels in investing in early-stage European startups, particularly in SaaS and enterprise tech. With a strong operational background, they leverage deep industry knowledge to support portfolio companies like GoCardless, Paddle, and Mews. Their focus spans business software, fintech, and future finance sectors, targeting transformative technologies like AI and cloud computing. Geographically, Notion Capital is centered on Europe, emphasizing markets in the UK, Germany, and France. Their strategy involves providing significant support through a dedicated platform team, aiding in product development, go-to-market strategies, and talent acquisition. They employ advanced AI for investment sourcing, ensuring they stay ahead in identifying high-potential startups. The fund typically leads Series A rounds, with an average check size of around €15 million, maintaining a portfolio of about 20 core investments. Recent notable investments include Bound, DataOps, and Resistant AI. Founders benefit from Notion's extensive network and strategic guidance, fostering growth and scaling efficiently. Key team members include Stephen Chandler, Jos White, and Itxaso del Palacio, who bring extensive experience from their entrepreneurial and investment backgrounds. This diverse and dynamic team is committed to a hands-on approach, driving success and innovation within their portfolio companies. Overall, Notion Capital stands out for its founder-friendly approach, combining strategic insights with robust financial backing, making it a formidable player in the European venture capital landscape.

New Venture Fund (Norwest Venture Partners) is a leading venture capital and growth equity investment firm with a diversified investment strategy. It focuses on early- to late-stage investments across various sectors, including consumer, enterprise, and healthcare. Norwest has a robust global presence with offices in North America, India, and Israel, enabling it to identify and support innovative companies worldwide. Notable investments by Norwest include companies like Dave, Gong, Swiggy, Udemy, Vuori, and Ritual. These investments demonstrate the firm's commitment to backing visionary leaders and transformative businesses. Norwest’s investment strategy includes providing not only capital but also strategic guidance and operational support to help portfolio companies scale and achieve significant growth. The firm has recently launched its $3 billion fund, NVP XVI, to continue empowering high-impact businesses. In recent years, Norwest has expanded its focus within the healthcare sector to include biotechnology, building on its successes in medical devices, diagnostics, and healthcare services. Norwest's notable exits include companies such as Opendoor, Talkspace, Udemy, Aporeto, CyberX, and Shape Security, among others. The firm is also committed to environmental, social, and governance (ESG) principles, investing in companies that prioritize sustainability and social impact​.

Novastar Ventures is one of Africa's largest and most established dedicated venture capital firms, founded in 2014 by Co-founders and Managing Partners Steve Beck and Andrew Carruthers. Headquartered in Nairobi, Kenya, with additional offices in Lagos, Nigeria and London — where Novastar Ventures Limited operates as an FCA-authorised entity — the firm runs a team of 10 across 4 partners. It has scaled across three vehicles: the East Africa Fund (Fund I), the Africa Fund II anchored by the European Investment Bank and British International Investment, and the new Africa People and Planet Fund III, which reached final close in early 2026 at $147 million and will for the first time deploy on a pan-African basis. Novastar leads rounds with an average cheque of approximately $1.5 million and a maximum of $5 million across seed, Series A, and Series B stages. The investment thesis is to back early- and growth-stage entrepreneurs building businesses that widen access, improve quality, and lower cost of basic goods and services for Africa's mass-market consumers — companies where positive social impact for low-income households is a natural by-product of commercial success. Sectors include e-mobility, agriculture, health tech, telecom, retail, energy, and fintech. Across 30 portfolio companies the fund has produced one unicorn: Moniepoint, a Nigerian fintech that achieved unicorn status in 2024 three years after Novastar's first cheque. Other standout portfolio names include Komaza, Africa's largest tree planter targeting one billion trees by 2030; BasiGo, an electric-bus Pay-as-you-Drive platform in East Africa; and Chowdeck. Novastar's pan-African expansion in Fund III, backed by institutional partners including Mitsui O.S.K. Lines, marks a significant broadening of geographic scope from its East and West Africa origins.

Novo Holdings is a premier life sciences investment firm based in Copenhagen, Denmark, with additional offices in Boston, San Francisco, London, and Singapore. The firm is wholly owned by the Novo Nordisk Foundation and manages an extensive portfolio aimed at generating long-term returns while advancing health and sustainability. Novo Holdings focuses on investments across biotechnology, medical technology, and digital health sectors, supporting companies at various stages, from early development to commercial phases. In 2023, the firm deployed DKK 3.6 billion, including significant investments in 4D Molecular, Alentis Therapeutics, and Lexeo Therapeutics. The firm's strategy emphasizes innovation in patient care and strong financial returns. Notably, Novo Holdings operates with an evergreen fund structure, allowing a long-term perspective on its investments. The firm actively engages with portfolio companies, often taking board positions to leverage its vast network and expertise. The investment team, led by Managing Partner Scott Beardsley, comprises professionals across major life science hubs. Key team members include Amit Kakar, Head of Novo Holdings Asia, and Anna Fan, Senior Partner in the Life Sciences Operating Committee. For startups seeking investment, Novo Holdings values groundbreaking science and robust clinical data, favoring companies with late preclinical or clinical stage compounds in biotech, and commercial stage entities in medtech and digital health

Novum Ventures Partners is a Kuala Lumpur-based venture capital management firm founded in 2018 and registered with the Securities Commission Malaysia as a Private Equity Management Company. The firm focuses on early-stage investments in healthcare, manufacturing, semiconductor, and technology-related sectors across Malaysia and the surrounding ASEAN region. Its investment thesis is grounded in disciplined research, analysis, and due diligence, with capital paired with intellectual support drawn from the partners' operating networks. The firm is led by Partners Ng Mun Hon and Ngu Chie Kieng, who together bring more than 50 years of combined business operating and private equity experience and a track record of historical exits at internal rates of return above 20 percent. Ng Mun Hon has 19-plus years of investment experience including 12 years in direct private-market investing at the venture and growth stages. Prior to Novum, he served as Vice President of Strategic Investments at Malaysia's National Innovation Agency, and from 2008 to 2012 was at Malaysia Venture Capital Management Berhad (MAVCAP) — the country's largest VC firm with RM 1.2 billion in assets under management — where he drove growth and pre-IPO investments and led MAVCAP's first Greentech investments, returning more than 20 percent IRR. Across their careers the partners have managed a global portfolio valued at more than RM 600 million. Novum writes seed and Series A cheques in the $100,000 to $500,000 range and maintains a deliberately discreet profile; specific portfolio company names are not publicly disclosed, reflecting a relationship-driven approach to the Malaysian and ASEAN private investment market rather than a high-volume dealflow strategy.

NRD Tech Ventures is the technology investing subsidiary of NRD Capital, a private equity firm headquartered in Atlanta, Georgia. The technology arm was announced in January 2019, formed following NRD Capital's strategic partnership with Atlanta-based Arke Systems and FRM Solutions — firms specializing in digital marketing strategy and CRM for franchise and multi-unit businesses. NRD Capital itself was founded in 2014 by Aziz Hashim, a serial multi-unit franchise operator who built an 80-unit empire spanning 14 brands including KFC, Domino's, Taco Bell, Moe's Southwest Grill, Pizza Hut, Popeye's, and PetValu in Canada. Hashim remains Founder and Managing Partner. NRD Capital is positioned as the first private equity fund sponsored and managed by a multi-unit franchisee, with more than 75 years of collective operational and financial experience across its team and 40-plus multi-unit franchise operators participating as limited partners. NRD Tech Ventures leads rounds and targets early- to mid-stage technology companies serving the restaurant, hospitality, franchise, and healthcare verticals. Portfolio companies include Harri, a talent management platform for hospitality teams; 1Huddle, a gamified employee training application; NEXT, a work-sharing platform for shift swapping; ShiftOne, a mobile employee motivation and operations management app; and ValyantAI, a customer-facing AI system for drive-thru QSR ordering. The firm's competitive edge is direct operating authority: its LP base manages thousands of restaurant locations and can serve as immediate commercial partners, pilot customers, and reference accounts for portfolio companies — a built-in go-to-market advantage that pure financial investors cannot replicate.

NTT DOCOMO Ventures is the corporate venture capital arm of NTT DOCOMO and the broader NTT Group, established in 2008 and headquartered in Tokyo with an additional team based in Silicon Valley. One of the largest and longest-running corporate venture funds in Japan, the firm's mission is to unite startups with the NTT Group — connecting shared talent and passion to deliver business collaborations across AI, telecommunications, content platforms, battery and power, security, big data, devices, and cloud infrastructure. The firm leads rounds and has invested across incubation, early, mid, and later pre-IPO stages, with typical cheques of $2 million to $3 million targeting minority stakes of approximately 20 percent or less. Across its 17-year history, NTT DOCOMO Ventures has invested in approximately 157 companies with between 18 and 55 portfolio companies reaching IPO or listing. The firm operates four successive funds: Fund I at JPY 15 billion (2008), Fund II at JPY 10 billion (2014), Fund III at JPY 20 billion (2018), and the DOCOMO Innovation Fund IV at JPY 15 billion, approximately $143 million, established January 2026. Current leadership is Yuko Sasahara as President, CEO, and Chief Culture Officer, and Jun Yasumoto as COO. Notable AI-era portfolio companies include ElevenLabs, the US voice AI unicorn; Ayar Labs, a silicon photonics unicorn; Wasabi, a cloud storage company; and AI model Inc., the firm's first Japanese lead-investor position in February 2024. A strategic Southeast Asia push is underway via Synexia Ventures, the NTT Group's first dedicated Southeast Asia investment vehicle, launched in November 2025. NTT DOCOMO Ventures' scale — spanning deep corporate relationships across one of the world's largest telecom groups — positions it as a credible bridge for portfolio companies seeking access to enterprise distribution channels across Japan and the broader Asia-Pacific region.

Nuclio Venture Builder is a Barcelona-based startup studio and venture capital fund founded in 2016 by serial Spanish entrepreneur Carlos Blanco alongside co-founders Maria Hidalgo, Alex Diaz, and Marc Torres. Headquartered at Pier01 in the Barcelona Tech City cluster, with additional presence in Madrid, Nuclio's thesis is to identify business models already validated and thriving in other geographies and then partner with top-tier local talent and capital to replicate them in Spain and the broader European market. Each project receives an initial investment of EUR 50,000 to EUR 150,000, delivered alongside a deeply integrated central services platform covering IT and software, communications and PR, human resources, legal, finance, and follow-on investment — significantly reducing the cost and time-to-market for each new venture. Nuclio leads rounds and has co-founded more than 20 ventures to date. Flagship successes include Housfy, the leading Spanish proptech platform; Games For a Living, co-founded by a former Activision Blizzard and King vice president; Kintai; Finteca; Prohipotecas; Verone; and Typs. Capital is deployed via the Nuclio Venture Fund, focused on early-stage opportunities in fintech, proptech, health tech, and edtech. The most recent disclosed investments include a EUR 300,000 pre-seed lead into Arediana, a preventive health and women's wellness company, and an early-stage VC round into Peimi in January 2025. The Nuclio ecosystem extends beyond the studio itself to include Nuclio Talent for digital headhunting, Nuclio School offering masters and bootcamps in product, growth, and technology, Nuclio Labs as a Web3 launchpad, and Nuclio Founders for first-time entrepreneurs. Co-founder Carlos Blanco also manages Encomenda VC as a parallel investment vehicle.

Nunatak Capital, based in Warsaw, Poland, is a venture capital firm that focuses on early-growth and seed-stage investments. The firm primarily invests in startups across Europe that leverage data science, data analytics, and optimization to create unique and scalable solutions. Nunatak's portfolio spans various sectors where technology and data science play a key role in driving value, from innovative new technologies to companies using existing tech to optimize their products. The firm typically invests between €100k and €1.5M, focusing on companies that can demonstrate market readiness and a clear product-market fit. Nunatak Capital is particularly drawn to startups that solve complex challenges, whether by creating novel technologies or by applying data science to enhance their business models. With a flexible investment approach, the firm supports visionary teams that align with its expertise in data science and entrepreneurship. Nunatak Capital is committed to working closely with its portfolio companies, not just by providing capital but also through strategic support to help them navigate the challenges of growth and innovation in a competitive market.

Nutreco is a global leader in animal nutrition and aquafeed, committed to sustainably feeding the growing global population. Headquartered in the Netherlands, Nutreco operates through two primary business lines: Skretting, which focuses on aquaculture, and Trouw Nutrition, which serves the livestock industry. The company’s overarching mission, known as "Feeding the Future," is to drive sustainability across the entire food production chain. Nutreco's strategy is centered around three main areas: supporting sustainable production through technology, advancing nutrition and animal health, and sourcing future protein ingredients. The company is heavily invested in developing sustainable alternatives to traditional feed ingredients, including the use of insect protein and other novel sources. This approach aims to reduce the environmental footprint of animal farming, which is crucial as feed ingredient production currently accounts for a significant portion of greenhouse gas emissions in the livestock industry. Innovation is a key pillar of Nutreco's operations, primarily driven by their NuFrontiers team, which focuses on breakthrough technologies that can transform the protein value chain. Nutreco has also been expanding its production capabilities in growth markets like Asia and Latin America, as well as optimizing its operations to increase agility and reduce costs. The company’s investments are aimed at not just expanding its market presence but also ensuring that its products and practices are aligned with global sustainability goals, making it a crucial player in the future of food production​.

NXTP Ventures, headquartered in Buenos Aires, is a leading venture capital firm in Latin America, focusing on early-stage tech startups. Their portfolio includes high-growth companies like Auth0, Nuvemshop, and Satellogic. With over 130 investments and numerous successful exits, NXTP is known for supporting innovative ventures in SaaS, logistics, and fintech sectors. They typically invest in Seed and Series A rounds, writing checks between $500k and $2 million. NXTP's strategy involves deep engagement with their portfolio companies, providing not just capital but also operational support, strategic guidance, and access to an extensive network of industry specialists and mentors. This approach has helped many of their investments achieve significant growth and market presence​ . The firm’s key team members, such as co-founder Ariel Arrieta, bring a wealth of experience in both investing and operating within the tech ecosystem. NXTP's investments are spread across Latin America, with a strong presence in Brazil, Argentina, Mexico, Chile, and Colombia.

Nyca Partners is a prominent venture capital firm that focuses on financial technology (fintech) investments. Established in 2014 and based in New York, Nyca Partners has over $870 million in assets under management. The firm invests across various stages, from seed to growth, with a particular emphasis on early-stage companies. Nyca's portfolio includes over 100 companies, with significant investments in well-known fintech startups such as Acorns, Affirm, and Revolut. Their investment strategy leverages their deep fintech expertise to connect innovative companies with the global financial system, fostering growth and scalability. Geographically, Nyca primarily invests in the U.S. but also considers global opportunities selectively. The firm’s approach is hands-on, providing active engagement and support to portfolio companies through strategic guidance and leveraging their extensive network. The team at Nyca Partners includes experienced professionals from leading financial institutions and fintech startups. Key team members include Hans Morris, Managing Partner, who brings a wealth of experience from his previous roles at Visa and Citigroup, and Ravi Mohan, Partner and COO, who has a strong background in financial services. Nyca's investment philosophy focuses on identifying transformative fintech solutions that can address critical needs in the financial sector. They seek out startups with innovative business models and strong growth potential, providing them with not only capital but also strategic support to help them succeed.

The NYU Entrepreneurial Institute is the hub for entrepreneurship across the NYU community, supporting students, faculty, and researchers in launching startups and commercializing new technologies. With its diverse set of programs, the Institute offers everything from hands-on accelerator programs like the Startup Bootcamp and Summer Launchpad, to resources for more advanced ventures through the Tech Venture Program and the Innovation Venture Fund. These programs help participants develop their ideas into scalable businesses with access to mentorship, funding, and training. Additionally, the Institute focuses on fostering an inclusive and diverse entrepreneurial ecosystem, with initiatives like the Female Founders Fellowship and the Inclusive Entrepreneurship programs. The Institute also connects startups with external investors and mentors, leveraging NYU's strong ties to New York City's vast entrepreneurial network. Through workshops, competitions, and dedicated support spaces such as the Leslie eLab, NYU provides a robust platform for founders at all stages of their startup journey, ensuring they have access to the tools and guidance necessary for success​.

NZVC (New Zealand Venture Capital) is a Christchurch-based early-stage venture capital firm, uniquely positioned as New Zealand’s first operator-run fund. Founded by Mark Pavlyukovskyy, Ajay Gupta, and Glen Anderson, NZVC focuses on investing in promising Kiwi startups, particularly at the pre-seed to Series A stages. The firm was launched with a strong belief in New Zealand's untapped potential, viewing the country as a future hub for global innovation, especially in a post-COVID world where remote work has become the norm. NZVC has successfully raised an initial $10 million, with plans to reach $15 million, to invest in sectors such as B2B SaaS, deep tech, fintech, and web3/cryptocurrency. The fund supports startups with more than just capital, offering expertise in areas like AI/ML, product development, fundraising, and marketing. Their mission is to help founders scale their companies globally, leveraging a network of Silicon Valley connections and local expertise. Some of their notable investments include companies like Seachange, which is innovating in hydrofoiling and electric car ferries, and Pyper Vision, which is developing fog-clearing drones for airports. NZVC’s investment philosophy emphasizes working closely with founders to navigate the challenges of building high-growth companies from New Zealand.

Oak HC/FT is a leading venture capital firm, established in 2014, with a focus on early to growth-stage investments in healthcare and fintech. Based in Greenwich, Connecticut, the firm is known for its deep expertise in these sectors, managing over $5.3 billion in assets across 85+ portfolio companies. Oak HC/FT's investment approach centers around supporting founders and companies that are driving structural change within two of the most complex industries: healthcare and financial services. The firm has backed a number of high-profile companies, including One Medical, Maven Clinic, and Rapyd, and has seen 49 successful exits to date, including several billion-dollar companies. Oak HC/FT prides itself on its long-term partnerships with founders, providing not only capital but also strategic support in talent acquisition, product development, and scaling operations. The firm's co-founders, Andrew Adams and Annie Lamont, bring decades of experience to the table, with Adams notably having been named one of the top healthcare investors globally. Oak HC/FT takes a hands-on approach, with its partners deeply involved in helping portfolio companies navigate regulatory landscapes, especially in the healthcare and fintech industries.

Oak Investment Partners is a leading multi-stage venture capital firm that focuses on high-growth opportunities across several sectors, including information technology, financial services technology, healthcare, and clean energy. Founded in 1978, Oak has invested over $9 billion in more than 525 companies worldwide. The firm is known for its hands-on approach, offering comprehensive support and strategic assistance through its extensive network of industry experts. Oak's portfolio includes notable companies such as Castlight Health, Zayo Group, Kayak, Benefitfocus, and Protean Electric, among others. Their investment strategy spans early to late-stage investments, including growth equity and PIPE (private investment in public equity) investments. Oak Investment Partners has built a reputation for its ability to identify transformative opportunities and support them through long-term, steady guidance​. The firm is headquartered in Norwalk, Connecticut, with additional offices in California. The team includes experienced professionals like Managing Partners Bandel Carano, Ed Glassmeyer, Fred Harman, and Ann Lamont, who bring deep domain expertise and a consistent investment philosophy to the table​.

Obvious Ventures, founded in 2014 and based in San Francisco, is a venture capital firm focused on early and growth-stage investments. The firm emphasizes investments that align with their "world positive" approach, targeting sectors like planetary health, human health, and economic health. This mission-driven investment strategy seeks to support companies that create a positive impact on the world while generating significant financial returns. Notable investments by Obvious Ventures include Beyond Meat, Medable, and Dexterity. Beyond Meat, known for its plant-based meat products, went public in 2019, marking a significant milestone for the firm. Medable provides a cloud-based platform for decentralized clinical trials, while Dexterity develops AI-driven robotic systems for managing warehouses. Obvious Ventures has a diverse portfolio of over 130 companies, with successful exits including Recursion Pharmaceuticals, Lilium, and Proterra. The firm's portfolio spans various industries such as AI, biotech, fintech, and sustainable consumer goods. The team at Obvious Ventures includes co-founders Ev Williams, James Joaquin, and Vishal Vasishth, who bring extensive experience in entrepreneurship and venture capital. They are committed to supporting visionary founders who are building transformative companies.

OCA Ventures, based in Chicago, is an early-stage venture capital firm that has been investing since 1999. The firm primarily targets technology, financial services, education, and healthcare technology sectors. Their investment strategy focuses on Seed, Series A, and Series B rounds, with typical initial investments ranging from $1 to $4 million. They often lead the rounds in which they participate. Notable companies in their portfolio include SpotHero, a parking app; Base CRM, a cloud-based customer relationship management software; Pangea, an online money transfer service; and Cleversafe, a cloud-based data storage system. Other significant investments include dv01, LogicGate, and Placer.ai. OCA Ventures is also known for its OCA EDGE program, which invests $50,000 to $200,000 in seed rounds of about $1.5 million or less. This program is designed to support early-stage startups with potential for dramatic growth. The firm has a strong track record of successful exits, including the sale of Cleversafe to IBM and the IPO of Marqeta. Led by CEO Jim Dugan and co-founders John Dugan and Peter Ianello, OCA Ventures leverages a robust network of strategic relationships to support their portfolio companies and drive their growth.

Oceans Ventures is an early-stage venture capital firm headquartered in New York, focusing on Pre-Seed and Seed Stage investments. They prioritize building strong, technically proficient teams and invest across sectors including B2B, SaaS, Cloud, AI, and Web3 infrastructure. The firm's notable investments include companies like Carbon Counts, Virtualness, and Lean Financial, which span industries from online gaming to financial services. The firm is managed by experienced professionals such as Brian Lew, Sara Barek, Glenn Handler, Joshua Rahn, and Steven Rosenblatt, who bring a hands-on approach to supporting their portfolio companies. Oceans Ventures emphasizes a collaborative model, actively assisting startups in recruiting top talent and refining their operational strategies​. Their investment strategy is characterized by a strong focus on teams with high integrity, deep domain expertise, and a commitment to growth. Oceans Ventures primarily invests in US-based companies located in talent-rich cities like New York, San Francisco, LA, and Boston.

Octopus Ventures, established in 2007 and headquartered in London, is a major venture capital firm in Europe with over £1.2 billion in assets under management. The firm invests in a diverse range of sectors, including B2B software, health tech, fintech, deep tech, consumer, climate, and bio. Their notable investments include well-known companies such as SwiftKey, ManyPets (formerly known as Bought By Many), Zoopla, LoveFilm, and Graze. Octopus Ventures focuses on supporting startups from pre-seed through to Series A and beyond, providing both funding and hands-on support to help companies scale. The firm is committed to backing founders with purpose-driven missions, emphasizing positive impact on people, communities, and the environment. Octopus Ventures employs a strategy that prioritizes long-term relationships with founders and deep sector expertise. They are particularly focused on disruptive technologies and innovative solutions that address significant global challenges. Recent investments reflect their commitment to sustainability and tech innovation, including companies like Token in fintech, Elliptic in blockchain analytics, and Minimum in climate tech. Led by a team of experienced investors and industry experts, Octopus Ventures ensures their portfolio companies receive the strategic guidance and operational support necessary for growth. The firm continues to expand its influence globally, aiming to foster innovation and drive positive change in the venture capital landscape.

OCV Partners is a Los Angeles-based venture capital firm, established with a mission to invest in companies that demonstrate significant growth potential, primarily in the technology and healthcare sectors. Their investment strategy is focused on mid- to late-stage companies, often in fields such as SaaS, fintech, biotech, and digital health. With a portfolio that includes innovative firms like Jukin Media, Scopely, and TaskUs, OCV Partners has positioned itself as a hands-on investor, providing both capital and operational support to help scale high-growth companies​. The firm prides itself on its diverse expertise, backing founders through every phase of their business journey. The OCV team brings decades of experience in building and scaling companies across various industries, from software and financial services to healthcare and media. They partner with startups not just to provide financial backing, but also to offer operational insight, helping businesses navigate the complexities of scaling. OCV Partners is well-known for its long-term mindset, focusing on building sustainable value through innovation and strong partnerships. The firm typically invests in companies at the seed to Series B stages, though they remain flexible and open to later-stage opportunities when appropriate.

Odyssee Venture is an independent Paris-based private-equity and venture-capital management company founded in 1999, headquartered at 26 rue de Berri in the 8th arrondissement, and one of the earliest AMF-accredited independent asset managers in France. The firm was co-founded by Mathieu Boillet and Sebastien Sassolas, who previously ran the venture-capital activities of the Banques Populaires Group through SPEF — historically France's first institutional venture investor. Over more than 25 years Odyssee has raised over EUR 750 million across FCPI, FIP, and FCPR vehicles and has financed roughly 200 French growth SMEs. Odyssee leads rounds and focuses on growth-stage investments in French SMEs spanning business and consumer products, financial services, healthcare and life sciences, SaaS, manufacturing and industrials, and e-commerce — deploying tickets from EUR 1 million to EUR 10 million with a typical average around EUR 5 million. Across 181 disclosed investments the portfolio includes BrightHeart, a prenatal ultrasound AI company for which Odyssee led an EUR 11 million Series A in January 2026 following five FDA approvals in 2025; Veesion, an AI shoplifting-gesture detection company that raised EUR 38 million to expand into the US; VitaDX, a urine-based cancer diagnostics firm; PeopleSpheres; Ekinops; Scaled Risk; and GymGlish. Odyssee's 25-year track record spans multiple economic cycles and fund formats, giving it an unusually deep bench of relationships across the French growth-company ecosystem. The firm's FCPI and FIP products are distributed to retail investors, making it one of the few French VCs with both institutional and retail LP exposure — a breadth that supports consistent capital formation across market conditions.

Offline Ventures, founded in 2020 and based in Mill Valley, California, is a venture capital firm focused on investing in early-stage startups across diverse sectors such as fintech, healthcare, and consumer technology. The firm is led by co-founders David Morin, Nate Bosshard, Brittany Morin, and James Higa, who bring extensive experience from various successful ventures. Notable investments by Offline Ventures include companies like Sunnyside, which focuses on application software; Kismet, a healthcare services company; and Clarasight, a business productivity software firm. They have a total of 48 investments and have seen several successful exits, including Diagram and Artifact. Offline Ventures is known for supporting startups that innovate at the intersection of technology and culture. They emphasize backing founders who are committed to building impactful and sustainable businesses. The firm also operates a venture studio to help incubate and develop new ideas into successful companies.

Oita Venture Capital Co., Ltd. is a regional Japanese venture capital and private equity firm headquartered in Oita City, Oita Prefecture, founded in 1997 and operating as the venture-capital arm of Oita Bank Ltd. One of Kyushu's longest-running institutional venture investors, the firm focuses almost exclusively on the Oita region and the broader Kyushu ecosystem, with occasional investments elsewhere in Japan. Oita VC specializes in growth capital, management buyouts, and turnaround investments in local small- and mid-sized enterprises, with particular emphasis on promising venture companies possessing differentiated technology or products and targeting IPO. Thematic priorities include agriculture and corporate farming, renewable energy, technology, and growth and turnaround opportunities for SMEs contributing to the regional economy. The firm leads rounds and operates a series of funds, with Oita VC Success Fund No. 6 as the current active vehicle. Across the firm's history, approximately 70 disclosed investments have been made across 61 companies, resulting in 11 IPO exits — notable listings include iQPS in satellite SAR imaging, QD Laser in semiconductor lasers, and Thinca in payments. Recent deployment has been measured at roughly one new investment per year, including INSPIRATION PLUS at Series A in 2024, GexVal in drug discovery in January 2025, and ATOMica at Series B-III in February 2026, the firm's most recent disclosed investment. Oita VC's role extends beyond financial return to regional economic development: by systematically backing and listing locally grown technology companies, the firm helps anchor high-skill employment and entrepreneurial activity in a prefecture that otherwise sits outside Japan's main technology corridors.

Okapi Venture Capital, established in 2005 and based in Newport Beach, California, focuses on seed and early-stage investments in the information technology and life sciences sectors. The firm has made 83 investments and has 18 notable exits, including companies like Welltok, Qualaroo, and CrowdStrike. Their portfolio includes a diverse range of companies such as Occuspace, which provides smart building solutions, Trellis Research in legal tech, and Daasity, which offers eCommerce analytics solutions. Other significant investments include Babylist, an online discovery platform for baby products, and ChromaCode, which uses data science for advanced molecular diagnostics. Okapi's investment strategy emphasizes supporting innovative startups with high growth potential, often leading seed and Series A rounds. The team is led by co-founders Marc Averitt and Sharon Stevenson, alongside partners like Jeff Bocan and John Waller, who bring extensive experience in venture capital and technology management. The firm is particularly active in the US market and collaborates with co-investors such as SaaS Ventures, Mucker Capital, and Stage Venture Partners, to foster the growth and success of its portfolio companies.

Olive Tree Capital is a dynamic venture capital firm headquartered in Boston, Massachusetts, focusing on early-stage investments across various tech-driven sectors. Notable investments include Uber, Postmates, and Lark, illustrating their keen eye for potential high-growth startups. With a strong portfolio in Artificial Intelligence, Machine Learning, Health & Wellness, and Big Data & Analytics, Olive Tree Capital seeks to back transformative companies from pre-seed through Series A stages. Their investment strategy is characterized by flexibility and an evergreen capital structure, allowing them to lead rounds and provide significant follow-on funding without the constraints of traditional fund timelines. This approach facilitates a long-term partnership with startups, aiming for substantial growth and successful exits, as demonstrated by their involvement in high-profile mergers and acquisitions like those of Bueno Finance and 10 Minute Squad. The firm’s geographic focus extends primarily across the United States, with a pronounced presence in the Boston area. Key team members, including Managing Partners Nichola Eliovits and Yamen Al-Hajjar, bring extensive experience in technology and biotechnology, reinforcing the firm's industry expertise and strategic guidance. Olive Tree Capital’s investment process emphasizes rigorous due diligence and a collaborative approach with co-investors like Y Combinator and Soma Capital. Startups seeking to engage with Olive Tree Capital are encouraged to present a compelling vision for innovation and market disruption, aligning with the firm’s commitment to transformative impact and sustainable growth​.

OTV (formerly Olive Tree Ventures) is a global venture capital firm specializing in digital health startups. Founded in 2015, OTV is based in Tel Aviv and New York, with additional offices in China to support its expansion into the Asia-Pacific market. The firm focuses on mid-growth stage companies developing cutting-edge digital health technologies that aim to revolutionize healthcare globally. OTV’s mission is to back innovative entrepreneurs who are building impactful solutions that address significant healthcare challenges. The firm’s $170 million fund is geared toward investing in companies offering groundbreaking technologies in telemedicine, genomics, AI-driven health platforms, and more. Notable portfolio companies include TytoCare, Lemonaid Health, and Scopio Labs, which are leaders in telehealth and healthcare innovation. OTV’s portfolio reflects its commitment to improving healthcare outcomes through technological advancement. With a leadership team boasting decades of experience in healthcare, technology, and private equity, OTV provides more than just capital. The firm actively supports its portfolio companies in scaling their businesses and navigating complex regulatory environments. By bridging innovation from the West with opportunities in North America, Israel, and Asia, OTV is uniquely positioned to help startups thrive in the growing global digital health market.

Oltre Venture — rebranded as Oltre Impact — is Italy's first impact-investing fund manager, founded in 2006 and headquartered in Milan. Managing Partners Luciano Balbo, who serves as President and founder, and Lorenzo Allevi as CEO have worked together since the firm's founding and lead a senior team with more than 50 cumulative years of private-equity and impact-investing experience. The firm is backed by a blue-chip institutional LP base including the European Investment Fund, Cassa Depositi e Prestiti, Intesa Sanpaolo, and many of Italy's leading family offices. Oltre operates across three successive fund vintages — Oltre I, Oltre II, and Oltre III, which reached a first close at EUR 53 million and has secured EUR 78 million against a EUR 100 million target. Across Funds I and II the firm deployed more than EUR 50 million into 30 social-impact companies. Oltre III has invested EUR 19 million in seven SMEs in its first 12 months. Oltre leads rounds with average check sizes of approximately EUR 5 million. The thematic focus spans healthcare and medtech, education, agriculture and food, sustainable housing, and economic development in Italy's less-developed regions. Portfolio companies include Cera, which became a unicorn in 2025 two years after Oltre's initial investment; Kippy; Faba; and medEA. Recent deals include the acquisition of a 60 percent stake in My English School in June 2025 to scale English-language schooling across Italy and Europe, a majority stake in Accadueo Impianti in February 2025, and an investment in Sepra in October 2025. Oltre's defining commitment is that commercial returns and social impact are complementary rather than competing. Every investment targets measurable improvement in access to services, quality of life, or environmental outcomes for underserved Italian communities.

Omega Venture Partners, based in Palo Alto, California, is a leading venture capital firm specializing in AI, machine learning, data, and automation. Their investment strategy is centered around identifying high-growth companies at the early-growth stage, particularly those that leverage AI to solve significant business challenges. Omega's portfolio includes companies like ZenBusiness, DataRobot, Verbit, and Elemental Machines, showcasing their focus on businesses that deliver transformative solutions across industries. Omega typically invests at the inflection point of a company’s growth, providing funding between $1M and $10M per round. Their thematic approach ensures they target companies with large-scale potential, helping them scale rapidly through access to a proprietary network of Fortune 500 executives and strategic partners. This network enables Omega to deliver high-value introductions, mentorship, and go-to-market strategies, adding significant value beyond capital. The firm's leadership, including Managing Partner Gaurav Tewari, has a deep track record in tech investing. Omega's expertise in guiding AI-driven companies makes them a preferred partner for entrepreneurs seeking to revolutionize industries like healthcare, fintech, and digital transformation.

OMERS Ventures, the venture capital arm of the Ontario Municipal Employees' Retirement System, focuses on investing in Series A to C companies across North America. Founded in 2011, the firm has backed several high-profile tech companies like Shopify and Wave. Their investment strategy centers on transformative technology sectors, including fintech, healthtech, proptech, and workplace technology. Typical initial investments range from $5 million to $25 million. OMERS Ventures has decided to withdraw from the European market to concentrate its efforts on North America. This strategic shift follows a challenging market environment in Europe and aims to leverage North America's relative economic stability. As part of this transition, the firm plans to open a new office in New York while maintaining its presence in Toronto and San Francisco. The leadership team includes Michael Yang, who emphasizes the importance of building strong relationships with founders and has a background in investing in emerging areas such as healthtech and IoT. For startups looking to engage with OMERS Ventures, demonstrating a deep understanding of the market and a clear vision for growth is essential. The firm values transparency and strong founder-investor relationships, aiming to support companies through various market challenges and opportunities.

Omnes Capital is a leading European private equity firm specializing in energy transition and innovation. Founded in 1999 and based in Paris, Omnes manages over €5 billion in assets. The firm's investment strategy focuses on four core areas: renewable energy, sustainable cities, deep tech venture capital, and co-investment. Notable investments include Direct Energie, Neoen, and BioSerenity. Omnes has made significant strides in the renewable energy sector with its Capenergie funds, which have invested over €2.5 billion across more than 60 projects in Europe, transforming developers into independent power producers. For example, their Capenergie 2 fund achieved a 15% net IRR, ranking among the top performers in Europe. Omnes also plays a crucial role in sustainable urban development by financing projects that support decarbonization and resilient city infrastructure. Their deep tech investments focus on disruptive technologies and startups pushing the boundaries of innovation. In addition to financial returns, Omnes is committed to responsible investment practices. The firm supports non-profits through the Omnes Foundation, which focuses on education, health, and social integration for children. Omnes is also a signatory of the United Nations Principles for Responsible Investment (PRI), underscoring their commitment to sustainability and ethical investment​.

OMRON Ventures Co., Ltd. is the corporate venture capital arm of OMRON Corporation — Japan's TSE-listed industrial automation and healthcare technology conglomerate — founded in July 2014 and headquartered in Minato-ku, Tokyo. The firm exists to create innovation driven by social needs by investing in and jointly developing with startups worldwide whose original technologies address OMRON's priority social challenges. Thematic focus areas span factory automation and industrial IoT, smart cities, digital and connected-health wearables, mobility, and energy management. OMRON Ventures operates two successive funds: OVC 1st Fund from 2014, which invested in approximately 20 startups across factory automation, healthcare, and smart cities; and OVC 2nd Fund established January 2022, which was certified by Japan's Ministry of Economy, Trade and Industry as the first Japanese corporate venture fund exempted from overseas-investment regulations — enabling expanded global deployment. Cumulative fund size across both funds is approximately JPY 15 billion, or roughly $100 million. Across 22 disclosed investments, portfolio companies include LIGHTz, a Skill Transfer AI company for manufacturing that received a Series A investment in May 2025; Sky Labs, a wearable cardiac monitoring company backed in November 2025; HQ Inc.; and avatarin Inc., both invested in February 2025. Vice President Christina Connelly leads the firm's international engagement. OMRON's corporate heritage runs deep: founder Kazuma Tateishi established Kyoto Enterprise Development in 1972, widely regarded as Japan's oldest private venture capital firm. This institutional history, combined with OMRON's active manufacturing and healthcare operations across Asia, the US, and Europe, gives its venture arm privileged visibility into frontier industrial and healthcare technology as a customer, collaborator, and investor simultaneously.

One Peak is a London-based growth equity fund focusing on scaling B2B software companies across Europe and Israel. With over $2 billion in assets under management, their typical investment range is between $15-$100 million, targeting rapidly growing firms with scalable business models and high potential. One Peak specializes in sectors like cybersecurity, infrastructure software, ESG solutions, DevOps, healthcare tech, and business intelligence. Notable portfolio companies include PandaDoc, Neo4j, and Spryker, alongside recent investments like PaySend and Akur8. Their strategy involves taking significant minority or majority stakes in high-growth businesses and providing ongoing support through follow-on investments, reserving 25% of funds for such purposes. Their proprietary PULSE platform helps them source opportunities efficiently. One Peak is known for leading rounds and co-investing, typically partnering with exceptional management teams to help these companies achieve category-defining success. Founders David Klein and Humbert de Liedekerke Beaufort lead the firm, bringing extensive experience in European growth investments. The team operates from their London base and has been highly active recently, closing their third fund at $1 billion, making it the largest in Europe for their segment. They’re open to collaborative partnerships with entrepreneurs who align with their values and long-term vision.

OneVentures is a leading Australian venture capital firm with a global focus, investing in technology and healthcare companies. The firm provides both equity and credit funding, with a particular emphasis on innovative products addressing significant market needs. OneVentures operates through several funds. Their Growth Fund V, which closed at $142 million, focuses on technology and tech-enabled companies, investing up to $20 million per company. This fund targets global themes such as remote work, digitization, clean energy, and healthcare. Additionally, the firm manages the Growth Credit Fund IV and the VGF Credit Fund, providing debt financing to high-growth tech companies, with investments ranging from $500,000 to $10 million per company. In the healthcare sector, OneVentures manages the $170 million Healthcare Fund III, investing in therapeutics, devices, and diagnostics with a clear commercial pathway. This fund is part of the Commonwealth Government’s Biomedical Translation Fund program, aiming to advance promising biomedical innovations. OneVentures' portfolio includes companies like Vaxxas, which develops needle-free vaccine delivery technology, and BiVACOR, known for its artificial heart technology. The firm is known for its hands-on approach, providing strategic guidance and leveraging its extensive network to support the growth and success of its portfolio companies.

One Way Ventures, founded in 2017 and headquartered in Boston, Massachusetts, is a venture capital firm dedicated to investing in immigrant founders. The firm focuses on seed-stage and early-stage companies across various sectors, including logistics, mobility, fintech, proptech, deep tech, consumer technology, healthcare, AI, machine learning, and robotics. Notable investments by One Way Ventures include Brex, Chipper Cash, Classtag, and Momentus. The firm has made significant exits, such as Legalpad, acquired in 2022, and Lynk, a satellite communications company​. The portfolio is diverse, featuring companies like Beacon, an AI-powered workflow automation platform for logistics; Brelyon, a deep tech company creating virtual screens; and Care Academy, a caregiver training platform. Co-founded by Semyon Dukach and Eveline Buchatskiy, One Way Ventures aims to support high-impact global companies driven by the unique perspectives and experiences of immigrant founders. The firm values equal opportunity and the collective potential of humankind, striving to eliminate borders as barriers to innovation and growth​.

OneRagtime is a venture capital platform that focuses on sourcing, financing, and scaling early-stage tech startups across Europe. Founded by Stéphanie Hospital and Jean-Marie Messier, the firm offers a unique investment model that combines flexibility with a fully digitized process, allowing investors to choose how they invest, either through deal-by-deal or via their funds like OneRagtime Rhapsody II and OneRagtime Paragon. The firm invests primarily in seed and Series A stages, with initial investments ranging from €0.5 million to €3 million, and can follow up with investments up to €10 million. OneRagtime targets startups in several sectors, including consumer platforms (gaming, marketplaces, social media, and the creator economy), artificial intelligence, cloud services, cybersecurity, and tech for social good (education, climate, and health). Notable portfolio companies include Groover, an artist promotion platform; PhantomBuster, a no-code data automation tool; and Benefiz, an HR tech platform for managing employee benefits. OneRagtime also emphasizes providing strategic, operational, and business development support to its portfolio companies to ensure their growth and success. With a community-driven approach, OneRagtime offers investors the opportunity to engage deeply with startups, providing not just capital but also expertise and networks to drive innovation and growth in the tech sector.

OneValley Ventures is the investment arm of OneValley — the global entrepreneurship platform formerly known as NestGSV and GSVlabs — founded in 2010 and headquartered in San Mateo, California. OneValley operates a SaaS-enabled innovation-ecosystem platform for accelerators, incubators, universities, enterprises, and governments, and uses the dealflow and data generated across that network as a competitive edge for its venture arm. The OneValley Fund was launched with a target deployment of approximately $25 million. The firm writes initial checks at the pre-seed and seed stages, typically in the $100,000 to $500,000 range, with reserves for follow-on investment in top performers through Series A. OneValley Ventures focuses thematically on enterprise software, big data, digital health, and education and learning technology — themes closely aligned with OneValley's ecosystem customers and the broader digital transformation and AI adoption trends. The firm is led by Co-Founders and Managing Directors Juan Scarlett, who leads investment strategy and growth-stage execution, and Alec Stapp, who focuses on pre-seed and seed deployment in enterprise, data, digital health, and edtech. Across 16 disclosed investments, the portfolio includes Besty AI, which received the most recent disclosed new investment in August 2024; Ovation; Pump; Trueface; NovelEffect; BidOps; NuvoCargo; Deepbench; and NERv Technologies. Notable exits include Tueo Health, acquired by Apple, and Kylie.ai, acquired by Directly. OneValley Ventures benefits from a structural advantage over standalone seed funds: access to dealflow sourced from thousands of startups that engage with the OneValley platform, combined with distribution relationships at universities, enterprises, and governments that can serve as early customers for portfolio companies.

ONSET Ventures was a storied early-stage venture capital firm founded in 1984 and headquartered in Menlo Park, California. The firm was co-founded by Terry Opdendyk, who served as Founder and General Partner across 30-plus years; David Kelley, the founder of IDEO; and Michael Levinthal. For nearly four decades ONSET specialized in seed and Series A investments in information technology and medical sectors — spanning infrastructure software, media, medical devices, drug delivery, mobile, diagnostics, and broader healthcare. The long-tenured partner bench included Rob Kuhling, who joined as Partner in 1987 following his time at Sun Microsystems, and Shomit Ghose. Over its lifetime ONSET raised nine funds and managed more than $1 billion in cumulative assets under management, backing more than 130 companies and producing four IPOs and 42 acquisitions. Notable exits include Adaptive Insights, the financial planning and analytics platform acquired by Workday for $1.55 billion; NeuroStar, an FDA-cleared transcranial magnetic stimulation device for major depressive disorder; CallidusCloud, a sales performance management platform acquired by SAP; and Apama Medical, a chronic-pain therapy company focused on basivertebral nerve treatment. The firm leads rounds and was particularly active at Series A with an average round size of approximately $8.8 million. ONSET Ventures was officially dissolved on November 27, 2023 and is no longer an active investor. Its website and portfolio documentation are maintained for historical reference. The firm's four-decade run across Silicon Valley's technology and medical-device buildout represents one of the most consistent early-stage track records of its era.

OpenOcean is a leading pan-European venture capital firm focusing on early-stage investments, particularly in Series A rounds, with an emphasis on data economy, B2B platforms, and enterprise software technology. Founded by the team behind MySQL and MariaDB, OpenOcean leverages its deep technical expertise to identify and support innovative startups that can rapidly scale and achieve global adoption. Notable investments include Truecaller, which has grown into a prominent global communications platform with over 200 million daily active users, and MariaDB, a leading open-source database company that recently went public on the New York Stock Exchange. Other significant portfolio companies include Nosto, a marketing automation tool, and Supermetrics, a global leader in marketing data integration tools. OpenOcean’s investment strategy is data-driven and focuses on sectors such as AI, data infrastructure, DevOps, and automation. They typically invest up to €6 million per company, leading or co-leading the investment rounds. The firm has a strong commitment to fostering diversity and transparency within its portfolio companies, ensuring a supportive environment for founders. The team at OpenOcean, with offices in Helsinki and London, is known for its hands-on approach, helping startups navigate the complexities of scaling their businesses and achieving sustainable growth. This approach has led to the creation of several unicorns and high-growth companies that are transforming their respective industries.

Open Opportunity Fund is a venture and growth investment firm backing B2B software companies across Enterprise IT, Fintech, and People Ops. We focus on business-critical software fueled by cloud, AI, and agentic systems, with 70% of our portfolio companies based in emerging tech hubs across the U.S. in regions often overlooked by traditional VC. Fund I was a $100M vehicle and on the strength of that success, we are now raising Fund II. Our strategy combines early and growth-stage investing to back category-defining companies that transform how organizations manage infrastructure, streamline financial operations, and empower their workforces. The firm was founded by Paul Judge and Marcelo Claure, successful entrepreneurs who have each built and scaled companies to successful exits.

Open Venture Capital (OVC) is an early-stage venture capital firm founded in 2022, based in Los Angeles and Baltimore. The firm focuses on investing in health, wellness, and consumer tech sectors, with a special emphasis on startups that address social determinants of health, preventative care, and well-being. OVC invests at the seed to Series A stages, typically offering advisory and incubation support alongside capital. The firm is led by Kimberley Nixon, an experienced operator-turned-venture-capitalist with a background in digital transformation and product development. She has worked with major companies like Under Armour and Headspace, which shaped OVC’s hands-on approach to venture building. OVC provides founders with strategic support through its "Office Hours" for problem-solving and a "Studio Model" to prepare startups for their first capital raises. OVC’s portfolio includes companies like No Limbits (adaptive apparel) and Pear Suite (care navigation), with the firm actively supporting founders who possess deep market insights and a strong connection to their target communities.

The OpenAI Startup Fund is a $175 million venture capital fund focused on investing in early-stage startups that are using artificial intelligence to create transformative change across a range of industries. These industries include healthcare, law, education, energy, and infrastructure. The fund seeks to partner with companies that are pushing the boundaries of AI technology, aiming to have a profound and positive impact on the world. Managed by a team with deep expertise in machine learning, engineering, talent acquisition, and operations, the fund leverages its connections with major investors like Microsoft. Although OpenAI itself is not an investor in the fund, the initiative is deeply tied to OpenAI’s mission of ensuring that artificial intelligence benefits all of humanity. The fund is particularly focused on empowering founders from underrepresented groups, emphasizing the importance of diversity in the tech industry. The OpenAI Startup Fund is not just a source of capital but also provides strategic support to its portfolio companies, helping them navigate the challenges of scaling AI-driven solutions. Startups that align with the fund’s mission of using AI to increase human productivity and address significant global challenges are encouraged to reach out. The fund represents a strategic effort to accelerate the deployment of ethical, impactful AI technologies that can reshape industries and improve lives.